Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Johnson & Johnson
Johnson & Johnson
Page 10 of 18
Health
It’s going to be a lot harder to get a Johnson & Johnson COVID-19 shot next week
By
Chris Morris
April 9, 2021
Magazine
Big Hospitals vs. Big Pharma: Which industry is most to blame for soaring health care costs?
By
Geoff Colvin
April 8, 2021
Health
If a COVID-19 vaccine does turn out to be dangerous, who’s on the hook?
By
David Meyer
April 7, 2021
Finance
BlackRock pledges to conduct a racial audit of its business
By
Marco Quiroz-Gutierrez
April 6, 2021
Health
Why your wait time between COVID vaccine doses may be different than your neighbor’s
By
Sy Mukherjee
April 3, 2021
Health
AstraZeneca COVID vaccine: German cities follow Canada in limiting rollout over clotting fears
By
David Meyer
March 30, 2021
Health
As COVID cases spike, the EU introduces tough new vaccine export controls
By
David Meyer
and
Jeremy Kahn
March 24, 2021
International
‘A bitter failure’: Europe in turmoil over abrupt decision to halt the AstraZeneca COVID vaccine
By
Vivienne Walt
,
David Meyer
and
Bernhard Warner
March 16, 2021
Leadership
How Abbott, Merck, and more health care and biopharma companies took care during COVID
By
Claire Hastwell
and
Great Place To Work
March 12, 2021
Health
J&J’s COVID vaccine gets the all-clear in Europe—but an immediate rollout is unlikely
By
David Meyer
March 11, 2021
Health
What most people get wrong about vaccine efficacy numbers
By
Sy Mukherjee
March 5, 2021
Conferences
Why improved access and awareness are key to a more equitable vaccine rollout
By
Andrew Marquardt
March 4, 2021
Health
Only one of the Big Four vaccine makers produced a COVID-19 winner. What happens next?
By
Kat Eschner
March 3, 2021
Health
Biden set to announce vaccine manufacturing partnership between Merck and Johnson & Johnson
By
Andrew Marquardt
March 2, 2021
Health
Biden officials warn Johnson & Johnson vaccine rollout may be slow
By
Andrew Marquardt
March 1, 2021
Most Popular
Economy
3 things Trump did in 24 hours to show that he's in control of American business
By
Eva Roytburg
AI
This CEO laid off nearly 80% of his staff because they refused to adopt AI fast enough. 2 years later, he says he'd do...
By
Nick Lichtenberg
Economy
Making billionaires illegal by taxing their wealth wouldn’t even fund the government for a year, budget expert says
By
Nick Lichtenberg